Skip to main content
Erschienen in: Brain Tumor Pathology 3/2020

24.05.2020 | Case Report

Primary spinal intramedullary Ewing-like sarcoma harboring CIC-DUX4 translocation: a similar cytological appearance as its soft tissue counterpart but no lobulation in association with desmoplastic stroma

verfasst von: Seiji Yamada, Jun Muto, John Clemente Aniceto De Leon, Tadashi Kumai, Keisuke Ito, Kazuhiro Murayama, Natsuko Hama, Yoshiko Nakano, Kaishi Satomi, Yasuhito Arai, Tatsuhiro Shibata, Tatsushi Inoue, Sumihito Nobusawa, Koichi Ichimura, Yuichi Hirose, Masato Abe

Erschienen in: Brain Tumor Pathology | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

The CIC-DUX4 translocation is the most common genetic alteration of small round cell sarcomas without EWSR1 rearrangement. These “Ewing-like sarcomas” usually occur in peripheral soft tissues, and rare primary central nervous system (CNS) tumors have been described. We report a rare case of primary spinal intramedullary Ewing-like sarcoma harboring CIC-DUX4 translocation. A 23-year-old man presented with weakness in the extremities. Magnetic resonance imaging revealed a large intramedullary tumor spanning C3–C5 with heterogeneous enhancement following gadolinium administration. Histologically, most of the tumor displayed dense myeloid proliferation composed of medium- to slightly small-sized primitive cells. Postoperatively, he received local adjuvant radiation therapy without tumor progression for 10 months. Target RNA sequencing analysis revealed the CIC-DUX4 fusion gene. Methylation array analysis resulted in a diagnosis of “methylation class CNS Ewing sarcoma family tumor with CIC alteration”. Although this tumor lacked characteristic histological features such as lobular structures in association with desmoplastic stroma, relatively uniform nuclei with prominent nucleoli and eosinophilic cytoplasm, which are often found in CIC-rearranged sarcomas of soft tissue, were identified. Recently, many CNS and soft tissue tumors require genetic analysis for precise diagnosis. To consider certain molecular testing, careful histological examination is essential.
Literatur
1.
Zurück zum Zitat Kawamura-Saito M, Yamazaki Y, Kaneko K et al (2006) Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation. Hum Mol Genet 15:2125–2137CrossRef Kawamura-Saito M, Yamazaki Y, Kaneko K et al (2006) Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation. Hum Mol Genet 15:2125–2137CrossRef
2.
Zurück zum Zitat Graham C, Chilton-MacNeill S, Zielenska M et al (2012) The CIC-DUX4 fusion transcript is present in a subgroup of pediatric primitive round cell sarcomas. Hum Pathol 43:180–189CrossRef Graham C, Chilton-MacNeill S, Zielenska M et al (2012) The CIC-DUX4 fusion transcript is present in a subgroup of pediatric primitive round cell sarcomas. Hum Pathol 43:180–189CrossRef
3.
Zurück zum Zitat Italiano A, Sung YS, Zhang L et al (2012) High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas. Genes Chromosomes Cancer 51:207–218CrossRef Italiano A, Sung YS, Zhang L et al (2012) High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas. Genes Chromosomes Cancer 51:207–218CrossRef
4.
Zurück zum Zitat Choi EY, Thomas DG, McHugh JB et al (2013) Undifferentiated small round cell sarcoma with t(4;19)(q35;q13.1) CIC-DUX4 fusion: a novel highly aggressive soft tissue tumor with distinctive histopathology. Am J Surg Pathol 37:1379–1386CrossRef Choi EY, Thomas DG, McHugh JB et al (2013) Undifferentiated small round cell sarcoma with t(4;19)(q35;q13.1) CIC-DUX4 fusion: a novel highly aggressive soft tissue tumor with distinctive histopathology. Am J Surg Pathol 37:1379–1386CrossRef
5.
Zurück zum Zitat Fletcher CDM, Bridge JA, Hogendoorn PCW et al (2013) WHO classification of tumours of soft tissue and bone, 4th edn. IARC, Lyon Fletcher CDM, Bridge JA, Hogendoorn PCW et al (2013) WHO classification of tumours of soft tissue and bone, 4th edn. IARC, Lyon
6.
Zurück zum Zitat Specht K, Sung YS, Zhang L et al (2014) Distinct transcriptional signature and immunoprofile of CIC- DUX4 positive round cell tumors compared to EWSR1-rearranged Ewing sarcomas—further evidence towards distinct pathologic entities. Genes Chromosomes Cancer 53:622–633CrossRef Specht K, Sung YS, Zhang L et al (2014) Distinct transcriptional signature and immunoprofile of CIC- DUX4 positive round cell tumors compared to EWSR1-rearranged Ewing sarcomas—further evidence towards distinct pathologic entities. Genes Chromosomes Cancer 53:622–633CrossRef
7.
Zurück zum Zitat Smith SC, Buehler D, Choi EYM et al (2015) CIC-DUX sarcomas demonstrate frequent MYC amplification and ETS-family transcription factor expression. Mod Pathol 28:57–68CrossRef Smith SC, Buehler D, Choi EYM et al (2015) CIC-DUX sarcomas demonstrate frequent MYC amplification and ETS-family transcription factor expression. Mod Pathol 28:57–68CrossRef
8.
Zurück zum Zitat Gambarotti M, Benini S, Gamberi G et al (2016) CIC-DUX4 fusion-positive round-cell sarcomas of soft tissue and bone: a single-institution morphological and molecular analysis of seven cases. Histopathol 69:624–634CrossRef Gambarotti M, Benini S, Gamberi G et al (2016) CIC-DUX4 fusion-positive round-cell sarcomas of soft tissue and bone: a single-institution morphological and molecular analysis of seven cases. Histopathol 69:624–634CrossRef
9.
Zurück zum Zitat Yoshida A, Goto K, Kodaira M et al (2016) CIC-rearranged sarcomas: a study of 20 cases and comparisons with Ewing sarcomas. Am J Surg Pathol 40:313–323CrossRef Yoshida A, Goto K, Kodaira M et al (2016) CIC-rearranged sarcomas: a study of 20 cases and comparisons with Ewing sarcomas. Am J Surg Pathol 40:313–323CrossRef
10.
Zurück zum Zitat Antonescu CR, Owosho AA, Zhang L et al (2017) Sarcomas with CIC-rearrangements are a distinct pathologic entity with aggressive outcome: a clinicopathologic and molecular study of 115 cases. Am J Surg Pathol 41:941–949CrossRef Antonescu CR, Owosho AA, Zhang L et al (2017) Sarcomas with CIC-rearrangements are a distinct pathologic entity with aggressive outcome: a clinicopathologic and molecular study of 115 cases. Am J Surg Pathol 41:941–949CrossRef
11.
Zurück zum Zitat Jiménez G, Shvartsman SY, Paroush ZJ (2012) The Capicua repressor–a general sensor of RTK signaling in development and disease. Cell Sci 125:1383–1391CrossRef Jiménez G, Shvartsman SY, Paroush ZJ (2012) The Capicua repressor–a general sensor of RTK signaling in development and disease. Cell Sci 125:1383–1391CrossRef
12.
Zurück zum Zitat Bielle F, Zanello M, Guillemot D et al (2014) Unusual primary cerebral localization of a CIC-DUX4 translocation tumor of the Ewing sarcoma family. Acta Neuropathol 128:309–311CrossRef Bielle F, Zanello M, Guillemot D et al (2014) Unusual primary cerebral localization of a CIC-DUX4 translocation tumor of the Ewing sarcoma family. Acta Neuropathol 128:309–311CrossRef
13.
Zurück zum Zitat Ito M, Ishikawa M, Kitajima M et al (2016) A case report of CIC-rearranged undifferentiated small round cell sarcoma in the cerebrum. Diagn Cytopathol 44:828–832CrossRef Ito M, Ishikawa M, Kitajima M et al (2016) A case report of CIC-rearranged undifferentiated small round cell sarcoma in the cerebrum. Diagn Cytopathol 44:828–832CrossRef
14.
Zurück zum Zitat Donahue JE, Yakirevich E, Zhong S et al (2018) Primary spinal epidural CIC-DUX4 undifferentiated sarcoma in a child. Pediatr Dev Pathol 21:411–417CrossRef Donahue JE, Yakirevich E, Zhong S et al (2018) Primary spinal epidural CIC-DUX4 undifferentiated sarcoma in a child. Pediatr Dev Pathol 21:411–417CrossRef
15.
Zurück zum Zitat Sturm D, Orr BA, Toprak UH et al (2016) New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell 164:1060–1072CrossRef Sturm D, Orr BA, Toprak UH et al (2016) New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell 164:1060–1072CrossRef
16.
Zurück zum Zitat Smith R, Owen LA, Trem DJ et al (2006) Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing’s sarcoma. Cancer Cell 9:405–416CrossRef Smith R, Owen LA, Trem DJ et al (2006) Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing’s sarcoma. Cancer Cell 9:405–416CrossRef
17.
Zurück zum Zitat Yoshida A, Sekine S, Tsuta K et al (2012) NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma. Am J Surg Pathol 36:993–999CrossRef Yoshida A, Sekine S, Tsuta K et al (2012) NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma. Am J Surg Pathol 36:993–999CrossRef
18.
Zurück zum Zitat Shibuya R, Matsuyama A, Nakamoto M et al (2014) The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma. Virchows Arch 465:599–605CrossRef Shibuya R, Matsuyama A, Nakamoto M et al (2014) The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma. Virchows Arch 465:599–605CrossRef
19.
Zurück zum Zitat Louis DN, Ohgaki H, Wiestler OD et al (2016) WHO classification of tumours of the central nervous system, revised, 4th edn. IARC, Lyon Louis DN, Ohgaki H, Wiestler OD et al (2016) WHO classification of tumours of the central nervous system, revised, 4th edn. IARC, Lyon
20.
Zurück zum Zitat Perry A (2016) WHO’s arrived in 2016! An updated weather forecast for integrated brain tumor diagnosis. Brain Tumor Pathol 33:157–160CrossRef Perry A (2016) WHO’s arrived in 2016! An updated weather forecast for integrated brain tumor diagnosis. Brain Tumor Pathol 33:157–160CrossRef
21.
Zurück zum Zitat Komori T (2017) Updated 2016 WHO classification of tumors of the CNS: turning the corner where molecule meets pathology. Brain Tumor Pathol 34:139–140CrossRef Komori T (2017) Updated 2016 WHO classification of tumors of the CNS: turning the corner where molecule meets pathology. Brain Tumor Pathol 34:139–140CrossRef
22.
Zurück zum Zitat Komori T (2020) Updating the grading criteria for adult diffuse gliomas: beyond the WHO2016CNS classification. Brain Tumor Pathol 37:1–4CrossRef Komori T (2020) Updating the grading criteria for adult diffuse gliomas: beyond the WHO2016CNS classification. Brain Tumor Pathol 37:1–4CrossRef
23.
Zurück zum Zitat Yokoo H, Kinjo S, Hirato J et al (2006) Fluorescence in situ hybridization targeted for chromosome 1p of oligodendrogliomas (in Japanese). Rinsho Kensa 50:761–766 Yokoo H, Kinjo S, Hirato J et al (2006) Fluorescence in situ hybridization targeted for chromosome 1p of oligodendrogliomas (in Japanese). Rinsho Kensa 50:761–766
24.
Zurück zum Zitat Sugita S, Arai Y, Tonooka A et al (2014) A novel CIC-FOXO4 gene fusion in undifferentiated small round cell sarcoma: a genetically distinct variant of Ewing-like sarcoma. Am J Surg Pathol 38:1571–1576CrossRef Sugita S, Arai Y, Tonooka A et al (2014) A novel CIC-FOXO4 gene fusion in undifferentiated small round cell sarcoma: a genetically distinct variant of Ewing-like sarcoma. Am J Surg Pathol 38:1571–1576CrossRef
25.
Zurück zum Zitat Yoshida A, Arai Y, Kobayashi E et al (2017) CIC break-apart fluorescence in situ hybridization misses a subset of CIC-DUX4 sarcomas: a clinicopathological and molecular study. Histopathology 71:461–469CrossRef Yoshida A, Arai Y, Kobayashi E et al (2017) CIC break-apart fluorescence in situ hybridization misses a subset of CIC-DUX4 sarcomas: a clinicopathological and molecular study. Histopathology 71:461–469CrossRef
26.
Zurück zum Zitat Ikota H, Nobusawa S, Arai H et al (2015) Evaluation of IDH1 status in diffusely infiltrating gliomas by immunohistochemistry using anti-mutant and wild type IDH1 antibodies. Brain Tumor Pathol 32:237–244CrossRef Ikota H, Nobusawa S, Arai H et al (2015) Evaluation of IDH1 status in diffusely infiltrating gliomas by immunohistochemistry using anti-mutant and wild type IDH1 antibodies. Brain Tumor Pathol 32:237–244CrossRef
27.
Zurück zum Zitat Kao YC, Sung YS, Zhang L et al (2016) Recurrent BCOR internal tandem duplication and YWHAE-NUTM2B fusions in soft tissue undifferentiated round cell sarcoma of infancy: overlapping genetic features with clear cell sarcoma of kidney. Am J Surg Pathol 40:1009–1020CrossRef Kao YC, Sung YS, Zhang L et al (2016) Recurrent BCOR internal tandem duplication and YWHAE-NUTM2B fusions in soft tissue undifferentiated round cell sarcoma of infancy: overlapping genetic features with clear cell sarcoma of kidney. Am J Surg Pathol 40:1009–1020CrossRef
28.
Zurück zum Zitat Yoshida Y, Nobusawa S, Nakata S et al (2018) CNS high-grade neuroepithelial tumor with BCOR internal tandem duplication: a comparison with its counterparts in the kidney and soft tissue. Brain Pathol 28:710–720CrossRef Yoshida Y, Nobusawa S, Nakata S et al (2018) CNS high-grade neuroepithelial tumor with BCOR internal tandem duplication: a comparison with its counterparts in the kidney and soft tissue. Brain Pathol 28:710–720CrossRef
29.
Zurück zum Zitat Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25:1754–1760CrossRef Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25:1754–1760CrossRef
30.
Zurück zum Zitat Capper D, Stichel D, Sahm F et al (2018) DNA methylation-based classification of central nervous system tumours. Nature 555:469–474CrossRef Capper D, Stichel D, Sahm F et al (2018) DNA methylation-based classification of central nervous system tumours. Nature 555:469–474CrossRef
31.
Zurück zum Zitat Lazo de la Vega L, Hovelson DH, Cani AK et al (2016) Targeted next generation sequencing of CIC-DUX4 soft tissue sarcomas demonstrates low mutational burden and recurrent chromosome 1p loss. Hum Pathol 58:161–170CrossRef Lazo de la Vega L, Hovelson DH, Cani AK et al (2016) Targeted next generation sequencing of CIC-DUX4 soft tissue sarcomas demonstrates low mutational burden and recurrent chromosome 1p loss. Hum Pathol 58:161–170CrossRef
32.
Zurück zum Zitat Lee JC, Villanueva-Meyer JE, Ferris SP et al (2019) Clinicopathologic and molecular features of intracranial desmoplastic small round cell tumors. Brain Pathol 30:213–225CrossRef Lee JC, Villanueva-Meyer JE, Ferris SP et al (2019) Clinicopathologic and molecular features of intracranial desmoplastic small round cell tumors. Brain Pathol 30:213–225CrossRef
33.
Zurück zum Zitat Ordóñez NG (1998) Desmoplastic small round cell tumor: I: a histopathologic study of 39 cases with emphasis on unusual histological patterns. Am J Surg Pathol 22:1303–1313CrossRef Ordóñez NG (1998) Desmoplastic small round cell tumor: I: a histopathologic study of 39 cases with emphasis on unusual histological patterns. Am J Surg Pathol 22:1303–1313CrossRef
34.
Zurück zum Zitat Zhang PJ, Goldblum JR, Pawel BR et al (2003) Immunophenotype of desmoplastic small round cell tumors as detected in cases with EWS-WT1 gene fusion product. Mod Pathol 16:229–235CrossRef Zhang PJ, Goldblum JR, Pawel BR et al (2003) Immunophenotype of desmoplastic small round cell tumors as detected in cases with EWS-WT1 gene fusion product. Mod Pathol 16:229–235CrossRef
35.
Zurück zum Zitat Al-Ibraheemi A, Broehm C, Tanas MR et al (2019) Desmoplastic small round cell tumors with atypical presentations: a report of 34 cases. Int J Surg Pathol 27:236–243CrossRef Al-Ibraheemi A, Broehm C, Tanas MR et al (2019) Desmoplastic small round cell tumors with atypical presentations: a report of 34 cases. Int J Surg Pathol 27:236–243CrossRef
Metadaten
Titel
Primary spinal intramedullary Ewing-like sarcoma harboring CIC-DUX4 translocation: a similar cytological appearance as its soft tissue counterpart but no lobulation in association with desmoplastic stroma
verfasst von
Seiji Yamada
Jun Muto
John Clemente Aniceto De Leon
Tadashi Kumai
Keisuke Ito
Kazuhiro Murayama
Natsuko Hama
Yoshiko Nakano
Kaishi Satomi
Yasuhito Arai
Tatsuhiro Shibata
Tatsushi Inoue
Sumihito Nobusawa
Koichi Ichimura
Yuichi Hirose
Masato Abe
Publikationsdatum
24.05.2020
Verlag
Springer Singapore
Erschienen in
Brain Tumor Pathology / Ausgabe 3/2020
Print ISSN: 1433-7398
Elektronische ISSN: 1861-387X
DOI
https://doi.org/10.1007/s10014-020-00366-y

Weitere Artikel der Ausgabe 3/2020

Brain Tumor Pathology 3/2020 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.